255 related articles for article (PubMed ID: 31273872)
1. Omission of radiation therapy following breast conservation in older (≥70 years) women with T1-2N0 triple-negative breast cancer.
Haque W; Verma V; Hsiao KY; Hatch S; Arentz C; Szeja S; Schwartz M; Niravath P; Bonefas E; Miltenburg D; Brian Butler E; Teh BS
Breast J; 2019 Nov; 25(6):1126-1133. PubMed ID: 31273872
[TBL] [Abstract][Full Text] [Related]
2. Omission of radiotherapy in elderly women with early stage metaplastic breast cancer.
Haque W; Verma V; Butler EB; Teh BS
Breast; 2018 Apr; 38():154-159. PubMed ID: 29413402
[TBL] [Abstract][Full Text] [Related]
3. Postmastectomy radiation therapy for triple negative, node-negative breast cancer.
Haque W; Verma V; Farach A; Brian Butler E; Teh BS
Radiother Oncol; 2019 Mar; 132():48-54. PubMed ID: 30825969
[TBL] [Abstract][Full Text] [Related]
4. Trends in utilization of hypofractionated whole breast irradiation (HF-WBI) in triple negative breast cancer (TNBC): a national cancer database (NCDB) analysis.
Rice SR; Feigenberg SJ; Hamza M; Molitoris JK; Bentzen SM; Tkaczuk KHR; Rosenblatt PM; Bellavance EC; Nichols EM
Breast Cancer Res Treat; 2019 Jun; 175(2):473-478. PubMed ID: 30796656
[TBL] [Abstract][Full Text] [Related]
5. Omission of Adjuvant Radiotherapy in the Elderly Breast Cancer Patient: Missed Opportunity?
Herskovic AC; Wu X; Christos PJ; Nagar H
Clin Breast Cancer; 2018 Oct; 18(5):418-431. PubMed ID: 29530585
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.
Abdulkarim BS; Cuartero J; Hanson J; Deschênes J; Lesniak D; Sabri S
J Clin Oncol; 2011 Jul; 29(21):2852-8. PubMed ID: 21670451
[TBL] [Abstract][Full Text] [Related]
7. Omitting radiation therapy in women with triple-negative breast cancer leads to worse breast cancer-specific survival.
Kindts I; Buelens P; Laenen A; Van Limbergen E; Janssen H; Wildiers H; Weltens C
Breast; 2017 Apr; 32():18-25. PubMed ID: 28012411
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer.
Zhai Z; Zheng Y; Yao J; Liu Y; Ruan J; Deng Y; Zhou L; Zhao P; Yang S; Hu J; We B; Wu Y; Zhang D; Kang H; Dai Z
JAMA Netw Open; 2020 Nov; 3(11):e2021881. PubMed ID: 33211105
[TBL] [Abstract][Full Text] [Related]
9. Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer.
Vo K; Ladbury C; Yoon S; Bazan J; Glaser S; Amini A
Breast Cancer; 2024 May; 31(3):485-495. PubMed ID: 38507145
[TBL] [Abstract][Full Text] [Related]
10. Comparison of outcomes between metaplastic and triple-negative breast cancer patients.
Polamraju P; Haque W; Cao K; Verma V; Schwartz M; Klimberg VS; Hatch S; Niravath P; Butler EB; Teh BS
Breast; 2020 Feb; 49():8-16. PubMed ID: 31675684
[TBL] [Abstract][Full Text] [Related]
11. Impact of CALGB 9343 Trial and Sociodemographic Variation on Patterns of Adjuvant Radiation Therapy Practice for Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-positive Breast Cancer: Analysis of the National Cancer Data Base.
Chu QD; Zhou M; Medeiros KL; Peddi P; Wu XC
Anticancer Res; 2017 Oct; 37(10):5585-5594. PubMed ID: 28982874
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy in Patients 70 Years and Older With Triple-Negative Breast Cancer.
Algan O; Zhao YD; Herman T
Clin Breast Cancer; 2016 Aug; 16(4):e99-e106. PubMed ID: 27292180
[TBL] [Abstract][Full Text] [Related]
13. T1-2N0M0 Triple-Negative Breast Cancer Treated With Breast-Conserving Therapy Has Better Survival Compared to Mastectomy: A SEER Population-Based Retrospective Analysis.
Li H; Chen Y; Wang X; Tang L; Guan X
Clin Breast Cancer; 2019 Dec; 19(6):e669-e682. PubMed ID: 31375327
[TBL] [Abstract][Full Text] [Related]
14. Metaplastic Breast Cancer: Practice Patterns, Outcomes, and the Role of Radiotherapy.
Haque W; Verma V; Naik N; Butler EB; Teh BS
Ann Surg Oncol; 2018 Apr; 25(4):928-936. PubMed ID: 29322287
[TBL] [Abstract][Full Text] [Related]
15. Management of pathologic node-positive disease following initial surgery for clinical T1-2 N0 esophageal cancer: patterns of care and outcomes from the national cancer data base.
Haque W; Verma V; Bernicker E; Butler EB; Teh BS
Acta Oncol; 2018 Jun; 57(6):782-789. PubMed ID: 29188742
[TBL] [Abstract][Full Text] [Related]
16. Benefit of adjuvant radiotherapy after breast-conserving therapy among elderly women with T1-T2N0 estrogen receptor-negative breast cancer.
Eaton BR; Jiang R; Torres MA; Kahn ST; Godette K; Lash TL; Ward KC
Cancer; 2016 Oct; 122(19):3059-68. PubMed ID: 27328114
[TBL] [Abstract][Full Text] [Related]
17. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy after surgery has significant survival benefits for patients with triple-negative breast cancer.
Yao Y; Chu Y; Xu B; Hu Q; Song Q
Cancer Med; 2019 Feb; 8(2):554-563. PubMed ID: 30632300
[TBL] [Abstract][Full Text] [Related]
19. Radiation therapy use and outcomes among older women with ER-positive and ER-negative stage I breast cancer.
Shen X; Anne PR; Keith SW; Wojcieszynski A; Mishra MV; Bar-Ad V; Showalter TN
Am J Clin Oncol; 2014 Jun; 37(3):241-7. PubMed ID: 23241502
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
